Boehringer Ingelheim Venture Fund co-led a series A round set to drive clinical work on UC Berkeley-founded Actym Therapeutics' immunotherapy pipeline.

JHU-founded restorative materials technology developer Lifesprout secured $28.5m in a round led by Redmile Group as it looks to move into regenerative medicine.

CAS Shanghai Institutes for Biological Sciences spinout Aptbio secured funding to enhance its mass spectrometry drug screening business.

The Parkinson's disease therapy developer completed a series A round featuring QB3-aligned Mission Bay Capital.

Dumac contributed to a round that took the total raised by the cancer screening system developer past the $130m mark.

EPFL spinout Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.

Duke University's endowment has supplied follow-on funding to Teamworks, which offers software for coordinating schedules within sports teams.

Disease diagnostics software provider Perspectum secured the return of Oxford and OSI to take its funding total to at least $41m.

NUI Maynooth spinout Avectas has added $20m to its coffers to develop cancer treatments.

Tsinghua-run incubator Lotus Lake Capital has backed Insight Lifetech, which develops treatment and diagnostic tools for coronary heart disease.